Gabriel Kane
Disclosure: I am in full compliance with all ethics and other policies for Market Realist research analysts. I am not invested in securities that I cover on Market Realist.
More From Gabriel Kane
Where Does Colgate-Palmolive’s Valuation Stand Compared to Peers?
As of January 27, 2017, Colgate-Palmolive (CL) was trading at a 12-month forward PE (price-to-earnings) ratio of 22.2x.
Key Drivers behind Colgate-Palmolive’s 4Q16 Margin Expansion
Colgate-Palmolive (CL) reported a rise of 160 basis points in its gross margins for 4Q16. In 2016, its gross margins rose 140 basis points.
How Do Analysts Rate Colgate-Palmolive and Its Peers?
Of the 20 analysts covering Colgate-Palmolive (CL) stock, three of them, or 15.0%, have rated the stock a “buy” as of January 27, 2017.
What Drove 4Q16 Organic Sales for Colgate-Palmolive’s Segments?
Colgate-Palmolive’s (CL) net sales fell 4.6% in 4Q16. However, the company’s organic sales rose 1.5%.
How Macro Factors Impacted Colgate-Palmolive’s 4Q16 Sales
Colgate-Palmolive (CL) reported sales of $3.7 billion for 4Q16. It missed consensus analysts’ sales estimate by 3.8%.
Insights into Colgate-Palmolive’s 4Q16 Earnings
Colgate-Palmolive (CL) matched analysts’ earnings estimates in 4Q16. In the last 11 quarters, excluding 4Q16, it exceeded analysts’ expectations seven times.
Why Colgate-Palmolive Stock Fell after 4Q16 Results
Colgate-Palmolive (CL) stock fell 5.2% and closed at $64.68 per share on January 27, 2017, after it announced its 4Q16 results.
Clorox Company Elects New Board of Directors
Clorox delivered adjusted EPS (earnings per share) of $1.36 in fiscal 1Q17. It missed consensus analysts’ earnings estimate of $1.42.
WestRock Company Declared Dividend of $0.40 per Share
WestRock (WRK) reported fiscal 1Q17 net sales of $3.45 billion, a fall of 0.7% compared to net sales of $3.47 billion in fiscal 1Q16.
How Did Gentex Corporation Perform in 4Q16?
Gentex (GNTX) reported 4Q16 net sales of $419.9 million, a rise of 3.5% compared to net sales of $405.6 million in 4Q15.